Session Information
Date: Tuesday, November 9, 2021
Title: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II (1565–1583)
Session Type: Poster Session D
Session Time: 8:30AM-10:30AM
Background/Purpose: IL-37 is an anti-inflammatory cytokine, member of IL-1 family, related to inflammatory and autoimmune diseases. Here we aimed to investigate the association of genetic variants of IL-37 and IL-37 plasma levels in relation to hyperuricemia/gout.
Methods: The study involved normouricemic controls (n=50), primary hyperuricemia (n=100), primary gout (n=100), tophaceous gout (n=25) and acute gout flare (n=18). All patients met the ACR gout classification criteria (1). Levels of plasma IL-37 were analysed using Enzyme-Linked Immunosorbent Assay. All coding regions and intron-exon boundaries of IL-37, exon 1-5, were amplified and sequenced directly. Differences of measured levels of IL-37 between groups were compared using Wilcoxon test. Variant allele frequencies were compared using binomial test and Fisher exact test.
Results: IL-37 levels were fairly similar across groups except for patients with tophaceous gout that had IL-37 levels significantly increased in contrast to control subjects (p=0.019) and gout patients (p=0.036). We identified 12 IL-37 genetic variants: five intron (rs28947188, rs2466448, rs3811045, rs3811048, rs2708944), and seven non-synonymous allelic variants (rs3811046, rs3811047, rs2708943, rs2723183, rs2723187, rs2708947, rs27231927). Of those, rs28947188 showed a significant under-presentation in hyperuricemic and gout cohorts (no variant found among all 243 patients) compared to normouricemic control group (minor allele frequency: MAF = 0.05) and European population (MAF = 0.083).
Conclusion: Variant rs28947188 showed a significant under-presentation in hyperuricemic/gout cohorts compared to European population MAF/normouricemic cohort. Plasma IL-37 is significantly up-regulated in patients with tophaceous gout compared to other groups. This evidence highlights the role of IL-37 in the pathogenesis of gout.
References:
Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74:1789-98.
Acknowledgement:
Supported by MHCR 023728, SVV 260 523 and BBMRI-CZ LM2018125
To cite this abstract in AMA style:
Navratilova A, Voclonová V, Hulejová H, Andrés Cerezo L, Pavlíková M, Bečvář V, Zavada J, Pavelka K, Senolt L, Stiburkova B. Interleukin-37: Associations of Plasma Levels and Genetic Variants in Gout [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/interleukin-37-associations-of-plasma-levels-and-genetic-variants-in-gout/. Accessed .« Back to ACR Convergence 2021
ACR Meeting Abstracts - https://acrabstracts.org/abstract/interleukin-37-associations-of-plasma-levels-and-genetic-variants-in-gout/